Daratumumab/Hyaluronidase Regimen

Preferred Label : Daratumumab/Hyaluronidase Regimen;

NCIt synonyms : Hyaluronidase-Daratumumab Regimen; Daratumumab-Hyaluronidase Regimen; Darzalex Faspro Regimen; Daratumumab and Hyaluronidase-fihj Regimen; Daratumumab/Recombinant Human Hyaluronidase Regimen; Hyaluronidase/Daratumumab Regimen;

NCIt related terms : Daratumumab and hyaluronidase monotherapy;

NCIt definition : A regimen containing daratumumab and hyaluronidase that may be used in the treatment of multiple myeloma and systemic light chain amyloidosis.;

NCI Metathesaurus CUI : CL1913835;

Codes from synonyms : 4962;

Details

Origin ID

C198002;

UMLS CUI

C5786708;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Daratumumab and Hyaluronidase-fihj [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Multiple Myeloma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients